natgillin/translations-raw huggingface dataset:
Memantine Accord belongs to a group of medicines known as anti-dementia medicines.
Zdravilo Memantin Accord sodi v skupino zdravil, znanih kot zdravila za zdravljenje demence.
Uncommon Confusion Uncommon Hallucinations1
Zaspanost Zmedenost Halucinacije1
Memantine Accordis used for the treatment of patients with moderate to severe Alzheimer's disease.
Zdravilo Memantin Accord uporabljamo za zdravljenje bolnikov z zmerno do hudo Alzheimerjevo boleznijo.
• Inflammation of the pancreas, inflammation of the liver and psychotic reactions Alzheimer's disease has been associated with depression, suicidal ideation and suicide.
• vnetje trebušne slinavke, vnetje jeter in psihotične reakcije Obstaja povezava med Alzheimerjevo boleznijo in depresijo, samomorilnimi mislimi in samomorom.
Other medicines and Memantine Accord
Druga zdravila in zdravilo Memantin Accord
In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substanceactive substance interaction of memantine with glyburide/metformin or donepezil was observed.
V raziskavah farmakokinetike (PK) posameznega odmerka pri mladih zdravih osebah ni bilo opaziti součinkovanja memantina z gliburidom/metforminom ali donepezilom.
The tablets can be divided into equal doses.
Tablete se lahko deli na enake odmerke.
Pack sizes of 14, 28, 30, 42, 50, 56, 98, 100 and 112 tablets are presented.
V škatli je po 14, 28, 30, 42, 50, 56, 98, 100 in 112 tablet.
In general, taking too much Memantine Accord should not result in any harm to you.
Na splošno zaužitje večjega odmerka zdravila Memantin Accord ne sme imeti škodljivih posledic.
Common (may affect up to 1 in 10 people):
Pogosti (prizadanejo lahko do 1 od 10 oseb):
Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4-and 6-hydroxymemantine, and 1-nitroso-3,5-dimethyl-adamantane.
Pri človeku so poglavitni metaboliti N3,5-dimetil-gludantan, izomerna mešanica 4- in 6-hidroksi-memantina in 1-nitrozo-3,5-dimetiladamantana.
This is increased to one tablet once a day (1 x 10 mg) in the second week and to 1 and a half tablet once a day (1 x 15 mg) in the third week.
V drugem tednu povišamo odmerek na eno tableto enkrat dnevno (1 x 10 mg) in v tretjem tednu na 1 in ½ tablete enkrat dnevno (1 x 15 mg).
What Memantine Accord is and what it is used for
Kaj je zdravilo Memantin Accord in za kaj ga uporabljamo
Do not use Memantine Accord after the expiry date which is stated on the carton and the blister after EXP.
Zdravila Memantin Accord ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na pretisnem omotu poleg oznake EXP. Rok uporabnosti se izteče na zadnji dan navedenega meseca.
Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbomedicinalis (interruption of potential entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate.
Pri odstranjevanju zdravilne učinkovine uporabljamo ustrezne standardne klinične postopke, kot so izpiranje želodca, medicinsko oglje (preprečevanje možne enterohepatične recirkulacije), acidifikacija urina, prisilna diureza.
Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer´s disease assessment scale (ADAS-cog) (p = 0.003) and CIBIC-plus (p = 0.004) at week 24 last observation carried forward (LOCF).
Pri bolnikih, zdravljenih z memantinom, se je pokazal statistično značilno boljši učinek kot pri bolnikih, ki so prejemali placebo pri primarnih ciljih študije: lestvica ocene Alzheimerjeve bolezni (ADAS-cog) (p = 0,003) in CIBIC-plus (p = 0,004) po 24 tednih prenosa zadnjih opaženih rezultatov naprej (LOCF).
Memantine Accord film-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 50 tablets, 56 tablets, 98 tablets, 100 tablets and 112 tablets.
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 30 tabletami, 42 tabletami, 50 tabletami, 56 tabletami, 98 tabletami, 100 tabletami in 112 tabletami.
Memantine Accord film-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 42 tablets, 56 tablets and 98 tablets.
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 42 tabletami, 56 tabletami in 98 tabletami.
How to take Memantine Accord 4.
Kako jemati zdravilo Memantin Accord 4.
Uncommon (may affect up to 1 in 100 people):
Občasni (prizadanejo lahko do 1 od 100 oseb):
If you take more Memantine Accord than you should
Če ste vzeli večji odmerek zdravila Memantin Accord, kot bi smeli
The following adverse reactions listed in the table below have been accumulated in clinical studies with memantine and since its introduction in the market.
V spodnji preglednici so navedeni podatki o neželenih učinkih zdravila, zbrani v kliničnih študijah memantina in od začetka trženja dalje.
Blister packs containing 28 tablets with 7 tablets of 5 mg, 7 tablets of 10 mg, 7 tablets of 15 mg and 7 tablets of 20 mg.
Pretisni omoti po 28 tablet s sedmimi tabletami po 5 mg, sedmimi tabletami po 10 mg, sedmimi po 15 mg in sedmimi tabletami po 20 mg.
Pack sizes of 14, 28, 42, 56 and 98 tablets are presented.
Na voljo so pakiranja z 14, 28, 42, 56 in 98 tabletami.
memantine hydrochloride
memantinijev klorid
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Podrobni podatki o tem izdelku so na voljo na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu.
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
Administration of Memantine Accord is not recommended in patients with severe hepatic impairment.
Dajanje zdravila Memantin Accord ni priporočeno bolnikom s hudo jetrno okvaro.
A pivotal monotherapy study of memantine in the treatment of mild to moderate Alzheimer's disease (MMSE total scores at baseline of 10-22) included 403 patients.
Temeljna študija memantina v monoterapiji pri zdravljenju bolnikov z blago do zmerno Alzheimerjevo boleznijo (skupna ocena ob vključitvi 10 do 22 točk na KPSS) je zajela 403 bolnike.
What Memantine Accord looks like and contents of the pack
Izgled zdravila Memantin Accord in vsebina pakiranja
15 mg tablet week 4 and beyond 20 mg tablets once a day Maintenance dose
4. teden in naprej 20 mg tableta enkrat dnevno Vzdrževalni odmerek
The recommended dose of Memantine Accord for adults and older people is 20 mg once a day.
Za odrasle in starejše je priporočeni odmerek zdravila Memantin Accord 20 mg enkrat dnevno.
Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70-150 ng/ml (0.5-1μmol) with large interindividual variations.
Ob dnevnih odmerkih 20 mg so v stanju dinamičnega ravnovesja dosežene plazemske koncentracije memantina v razponu od 70 do 150 ng/ml (0,5 - 1 µmol) ob veliki variabilnosti med posamezniki.
The use of medicinal products called amantadine (for the treatment of Parkinson´s disease), ketamine (a substance generally used as an anaesthetic), dextromethorphan (generally used to treat cough) and other NMDA-antagonists at the same time should be avoided.
Potrebno se je izogibati sočasni uporabi zdravil, kot so amantadin (za zdravljenje Parkinsonove bolezni), ketamin (snov, ki se uprablja kot anestetik), dekstrometorfan (splošna uporaba pri zdravljenju kašlja) in ostali zaviralci receptorjev NMDA.
Memantine Accord is not recommended for use in children below 18 years due to a lack of data on safety and efficacy.
Zaradi pomanjkanja podatkov o varnosti in učinkovitosti uporaba zdravila Memantin Accord pri otrocih pod 18 let ni priporočljiva.
Memantine Accord contains lactose
Zdravilo Memantin Accord vsebuje laktozo
Memantine Accord contains lactose.
Zdravilo Memantin Accord vsebuje laktozo.
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine Accord assessed by your doctor on a regular basis.
Vaš zdravnik naj redno ocenjuje klinično korist zdravila Memantin Accord.
Film-coated tablets 14 x 1 film-coated tablets 28 x 1 film-coated tablets 56 x 1 film-coated tablets 98 x 1 film-coated tablets
filmsko obložene tablete 14 x 1 filmsko obložena tableta 28 x 1 filmsko obložena tableta 56 x 1 filmsko obložena tableta 98 x 1 filmsko obložena tableta
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Podrobni podatki o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu.
Hypertension Uncommon Venous thrombosis/thromboembolism
Venska tromboza/tromboembolija
The patient should take two 10 mg film-coated tablets (20 mg) per day.
Bolnik naj jemlje dve 10 mg filmsko obloženi tableti (20 mg) na dan. Vzdrževalni odmerek
Women taking Memantine Accord should not breast-feed.
Ženske, ki jemljejo zdravilo Memantin Accord, ne smejo dojiti.
One treatment initiation pack contains 28 tablets in 4 blisters with 7 tablets of Memantine Accord 5 mg, 7 tablets of Memantine Accord 10 mg, 7 tablets of Memantine Accord 15 mg and 7 tablets of Memantine Accord 20 mg.
Eno pakiranje za začetno zdravljenje vsebuje 28 tablet v štirih pretisnih omotih s sedmimi tabletami zdravila Memantin Accord 5 mg, s sedmimi tabletami zdravila Memantin Accord 10 mg, s sedmimi tabletami zdravila Memantin Accord 15 mg in sedmimi tabletami zdravila Memantin Accord 20 mg.
Memantine Accord 5 mg, 10 mg, 15 mg; 20 mg film-coated tablets
Memantin Accord 5 mg, 10 mg, 15 mg, 20 mg
INNER CARTON FOR BLISTER PACK
NOTRANJA ŠKATLA ZA PRETISNI OMOT
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg tablets once a day) as described above.
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan (dve 10 mg tableti enkrat dnevno), kot je opisano zgoraj.
Memantine Accord should be administered orally once a day.
Zdravilo Memantin Accord jemljite peroralno enkrat dnevno.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (20 mg tablets once a day) as described above.
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan (20 mg tablete enkrat dnevno), kot je opisano zgoraj.
Balance disorders Uncommon Gait abnormal Very rare
Omotica motnje ravnotežja Neobičajna hoja Epileptični napadi
Uncommon Vomiting Not known Pancreatitis2
Zaprtje Bruhanje Pankreatitis2
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine.
Obvestite svojega zdravnika, če ste pred kratkim spremenili ali če nameravate bistveno spremeniti prehrano (npr. če preidete iz običajne hrane na strogo vegetarijansko prehrano), ali če imate ledvično tubularno acidozo (preveliko količino kislih spojin v krvi zaradi renalne disfunkcije (slabo delovanje ledvic)) ali če ste zboleli zaradi hudega vnetja sečil (strukture po kateri se prenaša seč).
EU/1/13/880/013 28 film-coated tablets
EU/1/1/3/880/013 28 filmsko obloženih tablet
Uncommon Fungal infections
Glivična okužba
From Week 4 on:
Od 4. tedna dalje
Hypromellose
Hipertenzija
In a study using orally administered 14C-memantine, a mean of 84 % of the dose was recovered within
V študiji peroralnega 14C-memantina se je izločilo 84 % odmerka v 20 dneh, več kot 99 % preko ledvic.
Your doctor will tell you whether your illness allows you to drive and to use machines safely.Also, Memantine Accord may change your reactivity, making driving or operating machinery inappropriate.
Vpliv na sposobnost upravljanja vozil in strojev Vaš zdravnik vam bo povedal, če zaradi vaše bolezni lahko varno vozite in varno upravljate s stroji.
How to store Memantine Accord 6.
Shranjevanje zdravila Memantin Accord 6.
Maintenance dose
Prilagajanje odmerka
7 x Memantine Accord 15 mg
7 x Memantin Accord 15 mg
- The active substance is memantine hydrochloride.
Zdravilna učinkovina je memantinijev klorid.
Memantine Accord contains the active substance memantine hydrochloride.
Zdravilo Memantin Accord vsebuje zdravilno učinkovino memantinijev klorid.
Maintenance dose The recommended maintenance dose is 20 mg per day.
Vzdrževalni odmerek Priporočeni odmerek je 20 mg na dan.
Film-coated tablets.
50 filmsko obloženih tablet.
Elevated liver function test Not known Hepatitis
Bolezni jeter, žolčnika in žolčevodov Pogosti Neznane pogostnosti zvišani jetrni funkcijski testi hepatitis
Hepatic impairment
Glavobol Utrujenost
How to take Memantine Accord
Kako jemati zdravilo Memantin Accord
Take one 20 mg tablet per day (pale red to greyred, scored) for 7 days.
Eno 20 mg filmsko obloženo tableto na dan (bledo rdeča do sivo rdeča z razdelilno zarezo) jemljite 7 dni.
Memantine Accord 20 mg film-coated tablets
Memantin Accord 20 mg filmsko obložene tablete
Excipientwith known effect: each film-coated tablet contains 73.80 mg lactose (as monohydrate).
Pomožna snov z znanim učinkom: ena filmsko obložena tableta vsebuje 73,80 mg laktoze (v obliki monohidrata).
Memantine Accord acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
Memantin Accord spada v skupino zdravil, ki se imenujejo antagonisti receptorjev NMDA. Memantin Accord deluje na receptorje NMDA in izboljša prenos živčnih signalov in spomin.
Memantine Accord 10 mg film-coated tablets
Memantin Accord 10 mg filmsko obložene tablete
Tablet cores for 5/10/15/20 mg film-coated tablets Lactose monohydrate
Jedro tablete pri 5/10/15/20 mg filmsko obloženih tabletah laktoza monohidrat mikrokristalna celuloza brezvodni koloidni silicijev dioksid krospovidon magnezijev stearat
Excipientwith known effect: each film-coated tablet contains 295.18 mg lactose (as monohydrate).
Pomožna snov z znanim učinkom: ena filmsko obložena tableta vsebuje 295,18 mg laktoze (v obliki monohidrata).
How does Memantine Accord work
Kako deluje zdravilo Memantin Accord
Hypromellose Polysorbate 80 Macrogol 400
Obloga tablete hipromeloza polisorbat 80 makrogol 400 titanov dioksid (E 171)
Memantine Accord 5 mg film-coated tablets Memantine Accord 10 mg film-coated tablets Memantine Accord 15 mg film-coated tablets Memantine Accord 20 mg film-coated tablets
Memantin Accord 5 mg filmsko obložene tablete Memantin Accord 10 mg filmsko obložene tablete Memantin Accord 15 mg filmsko obložene tablete Memantin Accord 20 mg filmsko obložene tablete
Each film-coated tablet contains 5 mg memantine hydrochloride equivalent to 4.15 mg memantine.
Ena filmsko obložena tableta vsebuje 5 mg memantinijevega klorida, kar ustreza 4,15 mg memantina.
What Memantine Accord contains
Kaj vsebuje zdravilo Memantin Accord
Memantine Accord 20 mg tablets are also available in perforated unit dose calendar blister in packsizes of 14x1, 28x1, 56x1 or 98x1 tablet.
Memantin Accord 20 mg filmsko obložene tablete so na voljo tudi v obliki perforiranega pretisnega omota za enkratno uporabo z natisnjenim koledarjem, v pakiranjih po 14 x 1, 28 x 1, 56 x 1 ali 98 x 1 tableta.
NAME OF THE MEDICINAL PRODUCT Memantine Accord 10 mg film-coated tablets memantine hydrochloride
IME ZDRAVILA Memantin Accord 10 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 5 mg film-coated tablets Memantine Accord 10 mg film-coated tablets Memantine Accord 15 mg film-coated tablets Memantine Accord 20 mg film-coated tablets memantine hydrochloride
Memantin Accord 5 mg filmsko obložene tablete Memantin Accord 10 mg filmsko obložene tablete Memantin Accord 15 mg filmsko obložene tablete Memantin Accord 20 mg filmsko obložene tablete memantinijev klorid
The 15 mg film-coated tablets are orange to grey-orange, oblong, coated tablets debossedwith "MT" on one side and "15" on the other side.
15 mg filmsko obložene tablete so oranžne do sivo oranžne, podolgovate, obložene tablete z vtisnjeno oznako "MT" na eni strani in vtisnjeno številko "15" na drugi strani.
Excipientwith known effect: each film coated tablet contains 183.13 mg lactose (as monohydrate).
Pomožna snov z znanim učinkom: ena filmsko obložena tableta vsebuje 183,13 mg laktoze (v obliki monohidrata).
Memantine Accord film-coated tablets are also available in perforated unit dose calendar blister in pack-sizes of 14x1, 28x1, 56x1 or 98x1 tablet.
Memantin Accord filmsko obložene tablete so na voljo tudi v obliki perforiranega pretisnega omota za enkratno uporabo z natisnjenim koledarjem, v pakiranjih po 14 x 1, 28 x 1, 56 x 1 ali 98 x 1 tableta.
Memantine Accord 10 mg tablets are also available in perforated unit dose calendar blister in pack-sizes of 14x1, 28x1, 56x1 or 98x1 tablet.
Memantin Accord 10 mg filmsko obložene tablete so na voljo tudi v obliki perforiranega pretisnega omota za enkratno uporabo z natisnjenim koledarjem, v pakiranjih po 14 x 1, 28 x 1, 56 x 1 ali 98 x 1 tableta.
Each film-coated tablet contains 15 mg memantine hydrochloride equivalent to 12.46 mg memantine.
Ena filmsko obložena tableta vsebuje 15 mg memantinijevega klorida, kar ustreza 12,46 mg memantina.
Week 3 (day 15-21): The patient should take one 15 mg film-coated tablet per day (orange to grey-orange) for 7 days.
3. teden (15.-21. dan): Bolnik naj 7 dni jemlje eno 15 mg filmsko obloženo tableto na dan (oranžna do sivo oranžna).
Each film-coated tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine - The other ingredients are lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, crospovidone, magnesium stearate, all in the tablet core; hypromellose, polysorbate 80, macrogol 400, titanium dioxide (E 171), iron oxide red (E 172), iron oxide yellow (E 172) all in the tablet coating
mikrokristalna celuloza, brezvoden koloidni silicijev dioksid, krospovidon in magnezijev stearat, vse v jedru tablete; in hipromeloza, polisorbat 80, makrogol 400, titanov dioksid (E 171), rdeči železov dioksid (E 172) in rumeni železov oksid (E 172) vse v oblogi tablete.
Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine - The other ingredients are lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, crospovidone, magnesium stearate, all in the tablet core; hypromellose, polysorbate 80, macrogol 400, titanium dioxide (E 171), all in the tablet coating
Pomožne snovi so: laktoza monohidrat, mikrokristalna celuloza, brezvoden koloidni silicijev dioksid, krospovidon, magnezijev stearat, vse v jedru tablete; hipromeloza, polisorbat 80, makrogol 400, titanov dioksid (E 171), vse v oblogi tablete.
Week 2 (day 8-14): The patient should take one 10 mg film-coated tablet per day (white, scored) for 7 days.
2. teden (8.-14. dan): Bolnik naj 7 dni jemlje eno 10 mg filmsko obloženo tableto na dan (bela z razdelilno zarezo).
EU/1/13/880/016 14 x 1 film-coated tablets EU/1/13/880/017 28 x 1 film-coated tablets EU/1/13/880/018 56 x 1film-coated tablets EU/1/13/880/019 98 x 1film-coated tablets
EU/1/13/880/016 14 x 1 filmsko obložena tableta EU/1/13/880/017 28 x 1 filmsko obložena tableta EU/1/13/880/018 56 x 1 filmsko obložena tableta EU/1/13/880/019 98 x 1 filmsko obložena tableta
EU/1/13/880/020 14 x 1 film-coated tablets EU/1/13/880/021 28 x 1 film-coated tablets EU/1/13/880/022 56 x 1 film-coated tablets EU/1/13/880/023 98 x 1 film-coated tablets
EU/1/13/880/020 14 x 1 filmsko obložena tableta EU/1/13/880/021 28 x 1 filmsko obložena tableta EU/1/13/880/022 56 x 1 filmsko obložena tableta EU/1/13/880/023 98 x 1 filmsko obložena tableta
Memantine Accord 20 mg film-coated tablets memantine hydrochloride
Memantin Accord 20 mg filmsko obložene tablete memantinijev klorid
The 20 mg film-coated tablets are pale red to grey-red, oblong, scored, coated tablets, debossed with "MT" divided by the score on one side and "20" divided by the score on the other side.
20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, podolgovate obložene tablete z razdelilno zarezo z vtisnjeno oznako "MT" na eni strani zareze in vtisnjeno številko "20" na drugi strani zareze.
The patient should take one 15 mg film-coated tablet per day for 7 days.
Bolnik naj sedem dni jemlje eno 15 mg filmsko obloženo tableto na dan. Od 4. tedna dalje
Memantine Accord 10 mg film-coated tablets memantine hydrochloride
Memantin Accord 10 mg filmsko obložene tablete memantinijev klorid
Contents of the pack and other information What Memantine Accord contains - The active substance is memantine hydrochloride.
Kaj vsebuje zdravilo Memantin Accord Zdravilna učinkovina je memantinijev klorid.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician´s interview based impression of change (CIBIC-plus): p = 0.025; Alzheimer´s disease cooperative study - activities of daily living (ADCS-ADLsev): p = 0.003; severe impairment battery (SIB): p = 0.002).
V temeljni klinični študiji pri skupini 252 bolnikov z zmerno do hudo Alzheimerjevo boleznijo (314točk na lestvici Kratkega preskusa spoznavnih sposobnosti (KPSS oz. MMSE ali "Mini-mental State Examination")) ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice Vtis sprememb na osnovi kliničnega intervjuja (CIBIC-plus - "Clinician's Interview-Based Impression of Change Plus Caregiver Input"): p = 0,025; Vprašalnik vsakodnevnih aktivnosti (ADCS-ADLsev oz.
The 5 mg film-coated tablets are white, oblong, coated tablets, debossed with "MT" on one side and "5" on the other side.
5 mg filmsko obložene tablete so bele, podolgovate obložene tablete z vtisnjeno oznako "MT" na eni strani in vtisnjeno številko "5" na drugi strani.
Each film-coated tablet contains 5/10/15/20 mg of memantine hydrochloride equivalent to 4.15/8.31/12.46/16.62 mg memantine - The other ingredients are lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, crospovidone, magnesium stearate, all in the tablet core; hypromellose, polysorbate 80, macrogol 400, titanium dioxide (E 171), and additional for Memantine Accord 15 mg and Memantine Accord 20 mg film-coated tablets iron oxide yellow and red (E 172), all in the tablet coating
Pomožne snovi so: laktoza monohidrat, mikrokristalna celuloza, brezvoden koloidni silicijev dioksid, krospovidon, magnezijev stearat, vse v jedru tablete; in hipromeloza, polisorbat 80, makrogol 400, titanov dioksid (E 171) ter dodatno pri zdravilu Memantin Accord 15 mg filmsko obležene tablete in pri zdravilu.
Memantine Accord 15 mg film-coated tablets are presented as orange to grey-orange, oblong, coated tablet, debossed with “MT” on one side and “15” on the other side.
Memantin Accord 15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalne obložene tablete z vtisnjeno oznako "MT" na eni strani in vtisnjeno številko "15" na drugi strani.
The patient should take one 10 mg film-coated tablet per day for 7 days.
Bolnik naj sedem dni jemlje eno in pol 10 mg filmsko obloženo tableto (15 mg) na dan.
Memantine Accord 10 mg film-coated tablets are presented as white, oblong, coated and scored tablet, debossed with “MT” divided by the score on one side and “10” divided by the score on the other side.
Memantin Accord 10 mg filmsko obložene tablete so bele, ovalne, obložene tablete z razdelilno zarezo in vtisnjeno oznako "MT" na eni strani zareze in vtisnjeno številko "10" na drugi strani zareze.